Remdesivir is about actual deaths. As far as I can read Remdesivir does nothing to stop the death. I want the FDA to look at the first 14 days of Leronlimab and give an EUA for the first 14 days of critical Covid, then give patients Remdesivir. How is it that with all the experts on pandemic epidemiology we have no therapeutics after two years that mitigate this disease? How is it that people with long haulers are experimenting with ivermectin by themselves? Does that mean ivermectin is more effective than Remdesivir?
Remdesivir, to me, is the most upsetting. More than any
Remdesivir is about actual deaths. As far as I can read Remdesivir does nothing to stop the death. I want the FDA to look at the first 14 days of Leronlimab and give an EUA for the first 14 days of critical Covid, then give patients Remdesivir. How is it that with all the experts on pandemic epidemiology we have no therapeutics after two years that mitigate this disease? How is it that people with long haulers are experimenting with ivermectin by themselves? Does that mean ivermectin is more effective than Remdesivir?
Top 10 Most Recent News Articles
Accuray, Samsung Push Boundaries with Imaging Deal
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
DKS Facing Class Action Over Stock Slump Allegations
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue ReadingTop 5 Most Recently Viewed Articles
Innovative Device Keeps Computer Active When You're Away
Introducing the PAD PAL: A Solution for Active Status Many people often face the challenge of maintaining their online presence while away from their computers. Whether for work, study, or gaming, the risk of being marked as inactive is a common concern. InventHelp's inventor, who understands this too well, has introduced a novel solution. This invention, named the PAD...
Continue Reading
Darktrace's Strategic Move: Acquiring Cado Security for Growth
Darktrace Plans to Enhance Cybersecurity with Cado Security Acquisition Darktrace, recognized as a frontrunner in AI for cybersecurity, has announced an ambitious plan to acquire Cado Security, a leading provider specializing in cloud investigation and response. This strategic move aims to strengthen Darktrace's capabilities in tackling the intricacies associated with...
Continue Reading
New York Times Takes Action Against Perplexity Over Content Use
New York Times Issues Cease and Desist to Perplexity The New York Times has recently moved to protect its intellectual property by sending a cease and desist notice to the AI startup, Perplexity. This action aims to address the unauthorized use of its content, which includes various outputs such as summaries derived from its articles. Details of the Cease and Desist...
Continue Reading
SEDA Experts Welcomes Fred Brettschneider to Advisory Board
SEDA Experts Welcomes New Senior Advisor SEDA Experts LLC, a prominent expert witness firm, is excited to announce that Fred Brettschneider has joined as a Senior Advisor, fortifying its alternative asset classes and investments expert witness practice. Experience Highlight: Fred Brettschneider Fred brings over 30 years of exceptional experience in the fields of...
Continue Reading
Recent Crypto Market Shifts: XRP Struggles, Bitcoin ETFs Surge
Recent Liquidation Patterns Impact XRP Traders The cryptocurrency market is currently witnessing some unexpected trading dynamics, particularly with XRP. Reports indicate a staggering 3,750% liquidation imbalance among long and short positions. This unusual trading activity sees a vast majority of over 97% of liquidations in XRP futures occurring from long positions, with...
Continue Reading